Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab
Wierda, William, Kipps, Thomas, Mayer, Jiří, Stilgenbauer, Stephan, Williams, Cathy D., Hellmann, Andrzej, Robak, Tadeusz, Furman, Richard R., Hillmen, Peter, Trneny, Marek, Dyer, Martin J.S., PadmanaТом:
9
Журнал:
Clinical Lymphoma and Myeloma
DOI:
10.3816/clm.2009.n.098
Date:
December, 2009
Файл:
PDF, 53 KB
2009
File converter
Більше результатів пошуку
More benefits 
